We are committed to delivering innovative, effective and useful medicines based on our formulas and filling unmet medical needs to improve our customers’ quality of life.
Molecules capable of slowing down or even reversing the biological process that causes hair loss have been used as monotherapies for many years. We’ve taken things a step further and developed a groundbreaking combination of three complementary active molecules that work in perfect synergy to promote hair growth at every step of regrowth.
Scientific rigour demands absolute discipline. Nothing can be left to chance. This does not mean that innovation can’t be integrated into processes, research and experimentation. Innovation makes it possible for us to develop models and products and offer ever more effective and targeted solutions to people’s problems. When it comes to the development of critical components of our business and products, innovation is at the heart of our business practices and strategic development!
Our scientific committee
After having developed several experimental compounds, doctor Sekhavat tests a combination of three molecules recognized for their effectiveness on himself. His efforts finally bear fruit when he applies this topical formula to his scalp every day for four weeks and experiences significant hair regrowth! After three months, his hair is full and healthy. He can’t believe it!
Excited by the impressive results, Dr. Sekhavat contacts a friend and a colleague who were well known in the local scientific community, pharmacologist Dr. Peter Ford and local entrepreneur Donna Steeves. After an NDA is signed, he presents all of his research and discoveries to them. Dr. Ford, the owner of a compounding pharmacy, puts his knowledge, equipment and staff at Dr. Sekhavat’s service and jump starts a more structured research and testing protocol immediately.
The TH-07 therapeutic formula based on the combination of three molecules known for their effectiveness is developed and stabilized. This innovative triple combination therapy offers unparalleled synergistic effectiveness to promote hair regrowth for men with androgenic alopecia. This new formula presents a unique opportunity for the two Moncton scientists.
Phase II clinical trials are performed in Dieppe (NB) to prove the efficacy of the synergetic effect of three proprietary blend molecules in stopping hair loss, increasing regrowth and making the hair thicker and darker. The results are outstanding, and product performance is far superior to that of the leading products on the market.
Multiple international patent applications are filed.
TH-07: International, Canada, China, USA, Europe, Macau, India
TH-16: Canada, USA, Europe, Hong Kong, China
Dr. Sekhavat and Dr. Ford have meetings with the U.S. Food and Drug Administration (FDA) and Health Canada with this proof of concept and are granted a Phase III approval and given a roadmap to market.
The FDA approves Triple Hair for a Phase III study under article 505(b) 2 conditional to a successful bioavailability study.
Triple Hair develops a second combination molecule from a specific proprietary blend of natural health ingredients for topical use and hair regrowth. Multiple clinical trials are run to determine the perfect concentration for this combination. The blend, whose patent is pending, proves to be more effective than Minoxidil 5%, one of the two gold standards in the market. Therapy-16 is a perfect option for people looking to avoid using anything chemical.
Dr. Asotra initiates the appropriate R&D workshops and regulatory work to establish a clear roadmap for the Phase III clinical trials greenlighted by the FDA and Health Canada. To this end, he sets up several working committees to guarantee reliable active ingredient sourcing, stability testing and pharmacokinetic testing.
Identification and meeting with potential pharma partners to accelerate the commercialization of TH-07 in major markets with unmet needs.
The Triple Hair team is set to initiate Phase III clinical trial in Canada and the United States for their TH-07 triple combination therapy. The trial will involve double-blinded, randomized, placebo-controlled, parallel-group tests, take place over a year and be conducted in multiple Canadian and U.S. sites.
PROTECTING OUR INTELLECTUAL PROPERTY
Triple Hair is continually filing new patents in markets with significant commercial potential as we develop our products through their life cycle.
